title: Reluctant gating of single N-type calcium channels during neurotransmitter-induced inhibition in bullfrog sympathetic neurons.
abstract: Whole-cell recordings have been used to extensively characterize the voltage-dependent inhibition of N-type calcium current induced by various neurotransmitters. Results from these studies have yielded several predictions on the effect of inhibition on N-channel gating, namely delayed channel opening and inhibition-induced reluctant openings. Previous single N-channel studies observed delayed channel opening but failed to find reluctant openings. However, strong depolarizations may be necessary to see reluctant openings, but this was not tested. We have examined N-channel gating at voltages depolarized to those used previously and found a neurotransmitter-induced open state that has properties predicted for the reluctant open state. The openings had lower open probability (P(o)) and brief open times compared to the dominant gating state observed in control (high P(o)). These reluctant events were reduced after strong depolarizing pulses used to reverse inhibition. The threshold voltage for activation of reluctant events was approximately 30 mV depolarized to that of the normal gating state (high P(o)). However, an action potential will provide sufficient depolarization to open reluctant N-channels.
authors.affiliation: Department of Pharmacology, Chonbuk University Dental School, Chonju, Korea 561-756.
authors.forename: H K
authors.initials: HK
authors.lastname: Lee
authors.forename: K S
authors.initials: KS
authors.lastname: Elmslie
mesh_terms: D000320:Adrenergic Fibers / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D020864:Calcium Channels, N-Type / Q000187:drug effects / Q000502:physiology*; D015640:Ion Channel Gating / Q000187:drug effects / Q000502:physiology*; D018377:Neurotransmitter Agents / Q000494:pharmacology / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology / Q000502:physiology; D018408:Patch-Clamp Techniques; D011892:Rana catesbeiana; D013566:Sympathomimetics / Q000494:pharmacology
chemical_list: D020864:Calcium Channels, N-Type; D018377:Neurotransmitter Agents; D013566:Sympathomimetics; D009638:Norepinephrine